Markets:

Overview

News

Currencies

International

Treasuries

Insmed Incorporated - Common Stock (NQ:INSM)

164.86 +1.34 (+0.82%)

Official Closing Price Updated: 4:15 PM EDT, Apr 1, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Insmed Incorporated - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Why Lung Disease Focused Stock Insmed Is Trading Higher Today? ↗

September 05, 2023

Insmed Incorporated (NASDAQ: INSM) shares are trading higher after the company released topline results from its Phase 3 ARISE study of ARIKAYCE in patients with newly diagnosed or recurrent...

Via Benzinga

Why Insmed Stock Is Soaring Today ↗

September 05, 2023

Investors applauded the company's latest clinical results.

Via The Motley Fool

Brady, Airbnb, Insmed And Other Big Stocks Moving Higher On Tuesday ↗

September 05, 2023

U.S. stocks traded lower, with the Dow Jones falling around 100 points on Tuesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

Benzinga's Top Ratings Upgrades, Downgrades For July 26, 2023 ↗

July 26, 2023

Via Benzinga

Insmed: Q1 Earnings Insights ↗

May 04, 2023

Via Benzinga

Insmed's Return On Capital Employed Insights ↗

February 28, 2023

Via Benzinga

A Preview Of Insmed's Earnings ↗

February 22, 2023

Via Benzinga

Analysts and Executives Converge February 2nd at the 30th Annual Emerald Groundhog Day Investment Forum

January 26, 2023

From Emerald Asset Management PA, LLC

Via Business Wire

Barclays Maintains Overweight Rating for Insmed: Here's What You Need To Know ↗

January 20, 2023

Via Benzinga

Analyst Expectations for Insmed's Future ↗

January 20, 2023

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

December 27, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Analyst Ratings for Insmed ↗

December 07, 2022

Via Benzinga

What 4 Analyst Ratings Have To Say About Insmed ↗

November 18, 2022

Via Benzinga

Why Insmed's Shares Fell 14.7% on Wednesday ↗

October 19, 2022

The biotech company is raising money to help it launch another drug, but it's diluting current shareholders in the process.

Via The Motley Fool

Insmed's Return On Capital Employed Insights ↗

August 18, 2022

Via Benzinga

Why Aptevo Therapeutics Shares Are Trading Higher By More Than 100%; Here Are 28 Stocks Moving Premarket ↗

December 12, 2022

Gainers

Via Benzinga

Coupa Software, Horizon Therapeutics And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗

December 12, 2022

U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2022 ↗

November 18, 2022

Upgrades

Via Benzinga

Insmed: Q1 Earnings Insights ↗

May 05, 2022

Insmed (NASDAQ:INSM) reported its Q1 earnings results on Thursday, May 5, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

Via Benzinga

Insmed's Return On Capital Employed Overview ↗

November 03, 2022

Benzinga Pro data, Insmed (NASDAQ:INSM) reported Q3 sales of $67.73 million. Earnings fell to a loss of $131.15 million, resulting in a 37.12% decrease from last quarter.

Via Benzinga

$1.4 Million Bet On This Real Estate Stock? 3 Stocks Insiders Are Buying ↗

November 03, 2022

Although US stocks closed lower on Wednesday, there were a few notable insider trades.

Via Benzinga

Insmed: Q3 Earnings Insights ↗

October 27, 2022

Insmed (NASDAQ:INSM) reported its Q3 earnings results on Thursday, October 27, 2022 at 07:30 AM. Here's what investors need to know about the announcement. Earnings Insmed missed estimated earnings by...

Via Benzinga

iRobot, Fox Factory, TripAdvisor And Some Other Big Gainers From Friday ↗

August 08, 2022

U.S. stocks closed mixed on Friday following the release of jobs data for July. Here is the list of some big stocks moving higher in the previous session.

Via Benzinga

Why Olaplex Shares Dipped Around 57%; Here Are 75 Biggest Movers From Yesterday ↗

October 20, 2022

Gainers Amprius Technologies, Inc. (NYSE: AMPX) jumped 77.3% to settle at $11.01 on Wednesday after the company announced it was awarded a $50 million cost-sharing grant from the U.S. Department of...

Via Benzinga

Why United Airlines Shares Are Trading Higher? Here Are 43 Stocks Moving In Wednesday's Mid-Day Session ↗

October 19, 2022

Gainers SenesTech, Inc. (NASDAQ: SNES) shares jumped 102.6% to $0.47 after declining over 3% on Tuesday. SenesTech, during August, posted a Q2 loss of $0.21 per share.

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

August 05, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Coinbase, MercadoLibre And Some Other Big Stocks Recording Gains On Thursday ↗

August 05, 2022

U.S. stocks closed mixed on Thursday following the release of weekly jobless claims data. Here is the list of some big stocks moving higher in the previous session.

Via Benzinga

Why NanoViricides Jumped Over 48%; Here Are 106 Biggest Movers From Yesterday ↗

August 05, 2022

Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) surged 109.2% to settle at $50.43 on Thursday after the company, and Amgen, announced an agreement under which Amgen will acquire the company for $52 per share...

Via Benzinga

Why ChemoCentryx Is Trading Higher By 110%, Here Are 95 Stocks Moving In Thursday's Mid-Day Session ↗

August 04, 2022

Gainers InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares jumped 178.5% to $12.45 after gaining over 12% on Wednesday.

Via Benzinga

Insmed's Return On Capital Employed Overview ↗

May 27, 2022

According to data from Benzinga Pro, during Q1, Insmed's (NASDAQ:INSM) reported sales totaled $53.11 million. Despite a 16.25% increase in earnings, the company posted a loss of $94.62 million.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.